Neuroprotective effects of tenuigenin in a SH-SY5Y cell model with 6-OHDA-induced injury

Neuroscience Letters

Volumn 497, Issue 2, 2011, Pages 104-109

  Liang, Zhigang ^a   Shi, Fang ^a   Wang, Yong ^a   Lu, Li ^a   Zhang, Zhanjun ^a   Wang, Xuan ^a   Wang, Xiaomin ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Anti oxidant; Dopaminergic neuron; Mitochondrial function; Parkinson's disease; Tenuigenin

Indexed keywords

CASPASE 3; GLUTATHIONE; MESSENGER RNA; NEUROPROTECTIVE AGENT; OXIDOPAMINE; SELEGILINE; SUPEROXIDE DISMUTASE; TENUIGENIN; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL DAMAGE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NERVE CELL LESION; NEUROBLASTOMA CELL; NEUROPROTECTION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANTIOXIDANTS; CELL LINE, TUMOR; DRUGS, CHINESE HERBAL; HUMANS; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; OXIDOPAMINE; PARKINSON DISEASE;

EID: 79956333078     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.04.041     Document Type: Article

References (24)

1. Blum D., Torch S., Lambeng N., Nissou M.-F., Benabid A.-L., Sadoul R., Verna J.-M. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Progress in Neurobiology 2001, 65:135-172.
2. Chen Y.-J, Huang X.-B., Li Z.-X., Yin L.-L., Chen W.-Q., Li L. Tenuigenin protects cultured hippocampal neurons against methylglyoxal-induced neurotoxicity. European Journal of Pharmacology 2010, 645:1-8.
3. Colnat-Coulbois S., Gauchard G., Maillard L., Barroche G. Bilateral subthalamic nucleus stimulation improves balance control in Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 2005, 76:780-787.
4. Corti O., Hampe C., Darios F., Ibanez P., Ruberg M., Brice A. Parkinson's disease: from causes to mechanisms. Comptes Rendus Biologies 2005, 328:131-142.
5. Dodel R.C., Du Y., Bales K.R., Zaodong L., Carvey P.M., Paul S.M. Caspase-3-like proteases and 6-hydroxydopamine induced neuronal cell death. Molecular Brain Research 1999, 64:141-148.
6. Egashira N., Yuzurihara M., Hattori N., Sakakibara I., Ishige A. Ninjin-yoei-to (Ren-Shen-Yang-Rong-Tang) and Polygalae radix improves scopolamine-induced impairment of passive avoidance response in mice. International Journal of Phytotherapy and Phytopharmacology 2003, 10:467-473.
7. Fernandez-Gomez F.J., Pastor M.D., Garcia-Martinez E.M., Melero-Fernandez de Mera R., Gou-Fabregas M., Gomez-Lazaro M., Calvo S., Soler R.M., Galindo M.F., Jord J. Pyruvate protects cerebellar granular cells from 6-hydroxydopamine-induced cytotoxicity by activating the Akt signaling pathway and increasing glutathione peroxidase expression. Neurobiology of Disease 2006, 24:296-307.
8. Jia H., Jiang Y., Ruan Y., Zhang Y., Ma X., Zhang J., Beyreuther K., Tu P., Zhang D. Tenuigenin treatment decreases secretion of the Alzheimer's disease amyloid [beta]-protein in cultured cells. Neuroscience Letters 2004, 367:123-128.
9. Jia Z., Misra H.P. Reactive oxygen species in in vitro pesticide-induced neuronal cell (SH-SY5Y) cytotoxicity: role of NF[kappa]B and caspase-3. Free Radical Biology and Medicine 2007, 42:288-298.
10. Kathy S.-C., Eleonora M., Jeffrey H.K. Etiology of Parkinson's disease: genetics and environment revisited. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:13972-13974.
11. Lee J.-Y., Kim K.Y., Shin K.Y., Won B.Y., Jung H.Y., Suh Y.-H. Effects of BT-11 on memory in healthy humans. Neuroscience Letters 2009, 454:111-114.
12. Li F.-Q., Cheng X.-X., Liang X.-B., Wang X.-H., Xue B., He Q.-H., Wang X.-M., Han J.-S. Neurotrophic and neuroprotective effects of tripchlorolide, an extract of Chinese herb Tripterygium wilfordii Hook F, on dopaminergic neurons. Experimental Neurology 2003, 179:28-37.
13. Luo D, Zhang Q., Wang H., Cui Y., Sun Z., Yang J., Zheng Y., Jia J., Yu F., Wang X., Wang X. Fucoidan protects against dopaminergic neuron death in vivo and in vitro. European Journal of Pharmacology 2009, 617:33-40.
14. Lv J., Jia H., Jiang Y., Ruan Y., Liu Z., Yue W., Beyreuther K., Tu P., Zhang D. Tenuifolin, an extract derived from tenuigenin, inhibits amyloid-β secretion in vitro. Acta Physiologica 2009, 196:419-425.
15. Park C.H, Choi S.H., Koo J.-W., Seo J.-H., Kim H.-S., Jeong S.-J., Suh Y.-H. Novel cognitive improving and neuroprotective activities of Polygala tenuifolia Willdenow extract, BT-11. Journal of Neuroscience Research 2002, 70:484-492.
16. Schapira A.H.V., Cooper J.M., Dexter D., Clark J.B., Jenner P., Marsden C.D. Mitochondrial complex I deficiency in Parkinson's disease. Journal of Neurochemistry 1990, 54:823-827.
17. Schober A. Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell and Tissue Research 2004, 318:215-224.
18. Shin K.Y., Lee J.-Y., Won B.Y., Jung H.Y., Chang K.-A., Koppula S., Suh Y.-H. BT-11 is effective for enhancing cognitive functions in the elderly humans. Neuroscience Letters 2009, 465:157-159.
19. Shin K.Y., Won B.Y., Heo C., Kim H.J., Jang D.-P., Park C.H., Kim S., Kim H.-S., Kim Y.-B., Lee H.G., Lee S.H., Cho Z.-H., Suh Y.-H. BT-11 improves stress-induced memory impairments through increment of glucose utilization and total neural cell adhesion molecule levels in rat brains. Journal of Neuroscience Research 2009, 87:260-268.
20. Sun X.L., Ito H., Masuoka T., Kamei C., Hatano T. Effect of Polygala tenuifolia root extract on scopolamine-induced impairment of rat spatial cognition in an eight-arm radial maze task. Biological & Pharmaceutical Bulletin 2007, 30:1727-1731.
21. Tyurina Y.Y., Kapralov A.A., Jiang J., Borisenko G.G., Potapovich A.I., Sorokin A., Kochanek P.M., Graham S.H., Schor N.F., Kagan V.E. Oxidation and cytotoxicity of 6-OHDA are mediated by reactive intermediates of COX-2 overexpressed in PC12 cells. Brain Research 2006, 1093:71-82.
22. Wang Y., Wang X., Liu L., Wang X. HDAC inhibitor trichostatin A-inhibited survival of dopaminergic neuronal cells. Neuroscience Letters 2009, 467:212-216.
23. Zhang D., Zhang J.-J., Liu G.-T. The novel squamosamide derivative FLZ protects against 6-hydroxydopamine-induced apoptosis through inhibition of related signal transduction in SH-SY5Y cells. European Journal of Pharmacology 2007, 561:1-6.
24. Zhao Y.J., Wee H.L., Au W.L., Seah S.H., Luo N., Li S.C., Tan L.C.S. Selegiline use is associated with a slower progression in early Parkinson's disease as evaluated by Hoehn and Yahr Stage transition times. Parkinsonism & Related Disorders 2011, 17:194-197.